Improving health through innovative tests that guide patient care

Our portfolio of innovative tests target unmet clinical needs along the patient care continuum. We are improving health through innovative tests that guide patient care.


Our prognostic tests go beyond traditional diagnostic approaches, providing physicians with a comprehensive understanding of disease aggressiveness, recurrence risk and treatment response.


Our diagnostic test provides increased clarity for difficult-to-diagnose melanocytic lesions that informs important patient management decisions.

Pharmacogenomic (PGx)

Our pharmacogenomic (PGx) test utilizes precision medicine, enabling tailored treatment strategies based on an individual's genetic profile and lifestyle factors.